CNS Pharmaceuticals, Inc. Annual Return On Equity in % from 2018 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
CNS Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from 2018 to 2023.
  • CNS Pharmaceuticals, Inc. Return On Equity for the quarter ending September 30, 2024 was 696 %.
  • CNS Pharmaceuticals, Inc. annual Return On Equity for 2023 was 33.3K %.
  • CNS Pharmaceuticals, Inc. annual Return On Equity for 2022 was -151 %, a 1.56% decline from 2021.
  • CNS Pharmaceuticals, Inc. annual Return On Equity for 2021 was -149 %, a 2.49% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 33.3K +33.4K Jan 1, 2023 Dec 31, 2023
2022 -151 -2.33 -1.56% Jan 1, 2022 Dec 31, 2022
2021 -149 -3.62 -2.49% Jan 1, 2021 Dec 31, 2021
2020 -145 +68.2 +31.9% Jan 1, 2020 Dec 31, 2020
2019 -214 -3.01K -108% Jan 1, 2019 Dec 31, 2019
2018 2.79K Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.